Skip to main content
ImmuneCited

Resveratrol 用于 Chronic Inflammation

C

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

结论

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

Key Study Findings

Review
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk.
Dose: None vs: None Outcome: None 效果: None None

研究人群: review of nutrition and lifestyle interventions for dyslipidemia and cardiometabolic risk

Review
Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

Review
Pathological interplay of NF-κB and M1 macrophages in chronic inflammatory lung diseases.
Dose: None vs: None Outcome: None 效果: None None

研究人群: review of NF-kB and M1 macrophages in asthma, COPD, and pulmonary fibrosis

Review
Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications.
Dose: None vs: None Outcome: None 效果: None None

研究人群: review of plant-derived anti-inflammatory compounds for chronic disease prevention

Key Statistics

5

研究数量

300

受试者

Positive

C

等级

Referenced Papers

Voprosy pitaniia 2023 19 次引用
Cancer investigation 2023 6 次引用
European journal of … 2020 91 次引用
International journal of … 2018 248 次引用
Current medicinal chemistry 2018 13 次引用
Current pharmacology reports 2015
Current drug targets 2006 92 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
150-500 mg/day
immunesupport:
250-500 mg/day trans-resveratrol

上限: No established UL; generally well-tolerated up to 1,500 mg/day

研究中使用的剂量

剂量 持续时间 效果 N
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Neutral --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --

最佳服用时间: With meals

Safety & Side Effects

已报告的副作用

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Joint pain at very high doses (>2.5 g/day)
  • Kidney issues at extremely high doses (case reports)

已知相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • CYP1A2, CYP3A4 substrates (may inhibit metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

可耐受最高摄入量: No established UL; generally well-tolerated up to 1,500 mg/day

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Resveratrol help with Chronic Inflammation?
Based on 5 studies with 300 participants, there is limited but promising evidence that Resveratrol may support Chronic Inflammation management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 150-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Joint pain at very high doses (>2.5 g/day), Kidney issues at extremely high doses (case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and Chronic Inflammation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。